Objectives : The 5MAX ACE is a new large bore aspiration catheter available for vessel recanalization for treatment of acute ischemic stroke (AIS). We report our initial experience with its use.
INTRODUCTION
Intra-arterial therapy (IAT) is a treatment option in patients with severe acute ischemic stroke (AIS) from arterial occlusion who do not respond to intravenous tissue plasminogen activator (tPA) or in whom tPA is contraindicated. Efficient and timely recanalization of the occluded vessel is an extremely important goal in IAT. With continuing advancements in the development of endovascular devices and techniques, more options are now available for management of AIS.
Using newer thrombectomy devices, better recanalization rates can be achieved in much shorter times compared to older devices. 5) 6) The 5MAX ACE reperfusion catheter (Penumbra, Inc., Alameda, CA, USA), a new large bore aspiration catheter available for vessel recanalization, was launched in July 2013. We report on our initial experience with the use of this catheter.
MATERIALS AND METHODS
This was a retrospective case series analysis study of patients undergoing IAT for AIS using the 5MAX ACE reperfusion catheter. The neuroendovascular procedure log of our institution was searched in order to identify all patients in whom the catheter was used since the time it became available. Patient demographics, clinical characteristics, and procedural data were obtained from chart review. Successful recanalization was defined as achievement of TICI score 2b-3.
Time to recanalization was defined as time from groin puncture to achievement of at least TICI score 2b
recanalization.
Technique
The 5MAX ACE reperfusion catheter can be used in several ways in the endovascular treatment of AIS.
Direct aspiration involves placement of a large bore aspiration catheter at the face of the clot and aspirating until the device becomes occlusive. 4 immediately adjacent to the clot, the microcatheter and microwire were removed. Manual suction was applied to the 5MAX ACE using a 0.6 dL syringe.
Once a good seal was obtained, the 5MAX ACE catheter was slowly pulled out, maintaining the aspiration.
During removal, simultaneous suction to the side port of the guide sheath was applied using a 0.6 dL syringe. Once the 5MAX ACE was removed from the body, the guide sheath was opened to allow back bleeding of possible clots, and then flushed forward once it was confirmed that there were no more clots (Fig. 1 ). This process using the tri-axial unit was re- 
RESULTS

Fifteen patients who underwent IAT for AIS from
July to October 2013, in whom the 5MAX ACE reperfusion catheter was used as described above, were included in the study. The characteristics of the patients are shown in Table 1 One patient with a basilar artery thrombus also had severe atherosclerotic stenotic disease that was stented with a Wingspan™ stent (Stryker, Kalamazoo, MI, USA).
In 5/15 (33%) patients, combined aspiration/stentriever thrombectomy was performed using Solitaire Patients in our small cohort were older with multiple medical co-morbidities, which might explain the outcomes. This should be further examined in larger Although head to head comparisons are inaccurate, recanalization rates using the 5MAX ACE, using either direct aspiration or as an adjunct to other devices, were comparable to the rates observed in TREVO 2 5) or the Penumbra Pivotal Stroke trial, and 7) or superior to those observed in the SWIFT trial. 6) Recently, a multi-center case series on the use of the 5MAX, 3MAX, and Neuron Max reperfusion catheters using direct aspiration as the primary thrombectomy method in 37 patients reported 100% successful recanalization at an even faster rate (mean 28.1 minutes) compared to our current series. 
CONCLUSION
The 5MAX ACE is a useful tool in the armamentarium of neurointerventionlists for treatment of AIS, either by direct aspiration or combined stent retriever/aspiration. Our review of our initial experience suggests that there were no procedural complications directly attributable to the device in our series.
Its use as a standalone technique seems feasible, and it may be advantageous with large clots in the ICA.
The potential for effective and faster recanalization using this device alone or in combination may be a good topic for future study.
